Gilead Sciences | GILD - Employees Total Number

Stock Price
138.85
Daily Change
-1.28 -0.91%
Monthly
-5.31%
Yearly
34.56%
Q2 Forecast
135.50

Gilead Sciences reported 17.6K in Employees for its fiscal year ending in December of 2024.





Employees Change Date
AbbVie 55K 5K Dec/2024
Agios Pharmaceuticals 486 103 Dec/2024
ALKERMES 1.8K 300 Dec/2024
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
Amgen 28K 1.3K Dec/2024
Biogen 7.6K 35 Dec/2024
BioMarin Pharmaceutical 3.04K 361 Dec/2024
Bristol-Myers Squibb 34.1K 0 Dec/2024
Coherus Biosciences 306 53 Dec/2023
Eli Lilly 47K 4K Dec/2024
Gilead Sciences 17.6K 400 Dec/2024
GlaxoSmithKline 69.4K 20.7K Dec/2022
Glaxosmithkline GBP 69.4K 20.7K Dec/2022
Incyte 2.62K 93 Dec/2024
J&J 138.1K 6.2K Dec/2024
Merck 75K 3K Dec/2024
Moderna 5.8K 200 Dec/2024
Neurocrine Biosciences 1.8K 400 Dec/2024
Novartis USD 101.7K 2.62K Dec/2022
Pfizer 81K 7K Dec/2024
PTC Therapeutics 939 49 Dec/2024
Puma Biotechnology 185 7 Dec/2023
Regeneron Pharmaceuticals 13.45K 1.6K Dec/2023
Sangamo BioSciences 405 73 Dec/2023
Sanofi 84.59K 3.41K Dec/2024
Sarepta Therapeutics 1.37K 58 Dec/2024
United Therapeutics 1.3K 137 Dec/2024
Vertex Pharmaceuticals 6.1K 700 Dec/2024